- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:10 | H.C. Wainwright bestätigt Kaufempfehlung für Alpha Tau Medical nach positiven Studiendaten | 1 | Investing.com Deutsch | ||
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 14:06 | Alpha Tau Medical stock rating reiterated at Buy by H.C. Wainwright | 1 | Investing.com | ||
| Di | Alpha Tau Medical: Aktie legt zu nach FDA-Antrag und bestätigter Kaufempfehlung | 1 | Investing.com Deutsch | ||
| Di | Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating | 1 | Investing.com | ||
| 05.01. | Alpha Tau Medical Ltd.: Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) | 182 | GlobeNewswire (Europe) | - Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review... ► Artikel lesen | |
| 05.01. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 18.12.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 14.12.25 | Alpha Tau Medical up sharply as brain cancer trial begins | 7 | Globes | ||
| 10.12.25 | H.C. Wainwright reiterates Buy rating on Alpha Tau Medical stock | 3 | Investing.com | ||
| 10.12.25 | Why Did Alpha Tau Medical (DRTS) Shares Jump Over 25% In After-Hours Trading? | 2 | Benzinga.com | ||
| 09.12.25 | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University | 169 | GlobeNewswire (Europe) | - First patient in the world treated with Alpha DaRT- in the brain - - According to the National Brain Tumor Society, glioblastoma is one of the most complex, deadly, and treatment-resistant cancers... ► Artikel lesen | |
| 09.12.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 02.12.25 | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer | 111 | GlobeNewswire (Europe) | JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT- , today announced that the FDA... ► Artikel lesen | |
| 02.12.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 20.11.25 | Alpha Tau Medical GAAP EPS of -$0.39 | 1 | Seeking Alpha | ||
| 20.11.25 | Alpha Tau Medical Ltd.: Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update | 1.373 | GlobeNewswire (Europe) | - Alpha DaRT pancreatic cancer patient treatments underway in U.S. multi-center pilot study - - Newly received radioactive material license for New Hampshire facility positions the Company for continued... ► Artikel lesen | |
| 20.11.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.10.25 | Alpha Tau Medical stock holds Buy rating at H.C. Wainwright after license win | 1 | Investing.com | ||
| 21.10.25 | Alpha Tau Medical Ltd.: Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness | 2 | GlobeNewswire (USA) | ||
| 21.10.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 50,72 | +3,03 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +2,89 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,970 | +0,99 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| GENEDX | 116,27 | -14,16 % | GeneDx Partners With Komodo Health to Advance Rare Disease Research | ||
| OUTSET MEDICAL | 5,650 | +23,63 % | Outset Medical, Inc.: Outset Medical Reports Unaudited Fourth Quarter and 2025 Results | SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,180 | -0,19 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| GERRESHEIMER | 27,860 | +1,68 % | Bechtle, Gerresheimer, HelloFresh, Kontron, Lanxess, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| UNITEDHEALTH | 289,45 | -2,11 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| BETA BIONICS | 18,510 | -7,77 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| ECKERT & ZIEGLER | 16,250 | -0,43 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| PROGYNY | 28,140 | +4,26 % | Progyny, Inc. - 8-K, Current Report | ||
| BRIGHTSPRING HEALTH SERVICES | 38,060 | +1,41 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| AIRSCULPT TECHNOLOGIES | 2,600 | +15,04 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board | MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 16,340 | -8,82 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 31,680 | -3,50 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
Das Unternehmen ALPHA TAU MEDICAL LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,02 % bei einem Aktienkurs von 7,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.